Open Bionics

Open Bionics

Private
Bristol, EnglandHealthcare & Life Scienceshttps://openbionics.com

Last Round

Crowdfunding

Jun 16, 2025

Total Funding Raised

$11M

Company Overview

Open Bionics is a UK-based company founded in 2014 by Joel Gibbard and Samantha Payne that develops and manufactures affordable, 3D-printed bionic arms for amputees. The company's flagship product, the Hero Arm, is a clinically approved, multi-grip myoelectric prosthesis designed to be functional, lightweight, and aesthetically empowering for adults and children with below-elbow limb differences. Open Bionics utilizes 3D scanning and printing to create custom-fitted devices, significantly reducing costs compared to traditional prosthetics. The company has notable partnerships with Disney, Marvel, and Lucasfilm to create superhero-themed prosthetic covers, aiming to turn disabilities into 'superpowers'. Open Bionics operates clinics in the UK and has expanded its clinical presence to the United States.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Health IoT

Business Model

B2B2C

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

bionic arm3D-printed prostheticsmyoelectric prosthesissuperhero armprosthetic armupper-limb prostheticsassistive technologymyoelectric controlcustom prosthesiscyborg armlimb differencemulti-grip handrobotic arm3D scanningprosthetic clinicspartial hand prosthesis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Open Bionics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Open Bionics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJun 16, 2025
DebtNov 12, 2024
Series AJan 14, 2019
SeedMar 22, 2017
GrantJan 16, 2017
Crowdfunding
Oct 14, 2013

Key People

Founding team and executive leadership

Samantha Payne

Co Founder And COO

Founding Team

Joel Gibbard

CEO Co-founder

Founding Team

Open Bionics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    Won the Hanger Clinics Innovation Award.

  • Jan 1, 2026

    Plans to launch a 'world-first technology' in 2026 after years of R&D.

Open Bionics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Open Bionics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Open Bionics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBristol, England
Employee Range61
Year Founded2014
Last FundingJun 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.